SCHEMBL7969787

SCHEMBL7969787

O=C1NC(=S)S/C1=C/c1ccc(Oc2ccccc2[N+](=O)[O-])cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 3/20 0.67
MMP13 P45452 3/20 0.67
ESRRA P11474 1/20 0.60
GSK3B P49841 2/20 0.57
CSNK2A2 P19784 1/20 0.56
CLK1 P49759 1/20 0.56
CSNK2B P67870 1/20 0.56
CSNK2A1 P68400 1/20 0.56
DYRK1A Q13627 1/20 0.56
DYRK1B Q9Y463 1/20 0.56
NAT1 P18440 3/20 0.55
CA2 P00918 1/20 0.55
EPHX1 P07099 1/20 0.55
MGAM O43451 1/20 0.55
GAA P10253 1/20 0.55
SI P14410 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
AKR1B1 P15121 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969788 1.00 MMP3 (0.67) MMP3MMP13ESRRAGSK3BCSNK2A2
SCHEMBL18103063 0.81 MMP3 (0.73) MMP3MMP13GSK3BCSNK2A2CLK1
SCHEMBL8177661 0.81 MMP3 (1.00) MMP3MMP13CSNK2A2CLK1CSNK2B
SCHEMBL8177658 0.81 MMP3 (1.00) MMP3MMP13CSNK2A2CLK1CSNK2B
SCHEMBL18103088 0.81 MMP3 (1.00) MMP3MMP13CSNK2A2CLK1CSNK2B
SCHEMBL4053689 0.79 CRHBP (0.58) MMP3MMP13GSK3BCSNK2A2CLK1
SCHEMBL4053687 0.79 CRHBP (0.58) MMP3MMP13GSK3BCSNK2A2CLK1
SCHEMBL4553082 0.79 MMP3 (0.68) MMP3MMP13CSNK2A2CLK1CSNK2B
SCHEMBL4553083 0.79 MMP3 (0.68) MMP3MMP13CSNK2A2CLK1CSNK2B
SCHEMBL8310830 0.77 TDP2 (0.75) MMP3MMP13GSK3BNAT1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed